ProPhase Labs, Inc.: Form 10-Q/A for the period ended Jun 30, 2017
Filed with the SEC on Aug 20, 2018 and accepted by EDGAR at Aug 20, 2018, 20:46 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Cost of revenue | 3 months2017-04-01 to 2017-06-30 | $1.8m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2017-01-01 to 2017-06-30 | $2.5m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2017-04-01 to 2017-06-30 | $140.0k | us-gaap:GrossProfit |
| Gross profit | 6 months2017-01-01 to 2017-06-30 | $225.0k | us-gaap:GrossProfit |
| Research and development | 3 months2017-04-01 to 2017-06-30 | $224.0k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2017-01-01 to 2017-06-30 | $258.0k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2017-04-01 to 2017-06-30 | −$886.0k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2017-01-01 to 2017-06-30 | −$1.6m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2017-04-01 to 2017-06-30 | $574.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2017-01-01 to 2017-06-30 | $1.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2017-04-01 to 2017-06-30 | −$2.3m | us-gaap:NetIncomeLoss |
| Net income | 6 months2017-01-01 to 2017-06-30 | $41.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2017-04-01 to 2017-06-30 | −$0.14 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2017-01-01 to 2017-06-30 | $2.34 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2017-04-01 to 2017-06-30 | −$0.14 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2017-01-01 to 2017-06-30 | $2.44 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2017-04-01 to 2017-06-30 | 16,943 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2017-01-01 to 2017-06-30 | 17,680 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2017-01-01 to 2017-06-30 | −$667.0k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2017-01-01 to 2017-06-30 | $132.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months2017-01-01 to 2017-06-30 | $1.9m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2017-06-30 | $37.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-06-30 | $42.2m | us-gaap:AssetsCurrent |
| Total assets | At period end2017-06-30 | $50.1m | us-gaap:Assets |
| Current liabilities | At period end2017-06-30 | $4.2m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2017-06-30 | $45.9m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001493152-18-012358. Last ingested by Listed: Oct 24, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.